Health Sciences

Potential new therapeutic targets to treat melanoma

Penn Medicine research shows that a relative lack of DOPA, and not simply susceptibility to sun damage, helps explain why melanoma is much more common in people with light skin tones.

Alex Gardner

Chewing to curb COVID

Penn Medicine will conduct a new clinical trial to evaluate the safety and efficacy of a chewing gum designed by School of Dental Medicine researchers to trap SARS-CoV-2 in the saliva.

Katherine Unger Baillie

A summer optimizing obstetrics health care

Second-year student Antoilyn Nguyen spent their summer as a researcher analyzing labor and delivery charts as part of a long-term cohort study to standardize labor induction for better and more equitable results.

Tina Rodia

In the News

Integrating genetic testing orders into EHRs saves time, study says

A study from the Perelman School of Medicine suggests that time is saved when clinicians are able to order genetic testing through electronic health record systems.



FDA seems poised to approve a new drug for ALS, but does it work?

Holly Fernandez Lynch of the Perelman School of Medicine says that the FDA’s current trajectory has been characterized by increased willingness to accept weaker evidence.



University of Pennsylvania receives $55 million gift to study, treat hereditary cancers

The $55 million gift from alumni Mindy and Jon Gray will be used to establish the Basser Cancer Interception Institute, featuring a statement from President Liz Magill.


Los Angeles Times

The fear of public places in the age of COVID: Is it agoraphobia or something else?

Sandy Capaldi of the Perelman School of Medicine defines agoraphobia and explains what distinguishes it from other anxiety disorders in the context of the pandemic.


Philadelphia Inquirer

COVID boosters take aim just at omicron. This Penn lab is going after coronaviruses the world hasn’t seen yet

In Drew Weissman’s lab at the Perelman School of Medicine, researchers like Mohamad-Gabriel Alameh, Benjamin Davis, and Garima Dwivedi are developing pan-coronavirus vaccines to guard against future variants.